Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026)
Varex Imaging's (VREX) quarterly Cash from Financing Activities came in at -$29.3 million in Q2 2026, down 4085.71% year-on-year from $735125.4 in Q2 2025, and down 1731.25% on a QoQ basis from -$1.6 million in Q1 2026.
Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Cash from Financing Activities data on file, last reported at -$29.3 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 4085.71% year-over-year to -$29.3 million in Q2 2026; TTM through Apr 2026 was -$231.0 million, a 286.44% decrease from a year earlier, with the FY2025 full-year figure at -$75.9 million, down 2200.0% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$29.3 million, down from -$1.6 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for VREX reached as high as $124.9 million in Q1 2025 and fell as low as -$201.2 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged -$8.2 million across 5 years, with a median of -$700000.0 in 2023.
- On a YoY basis, Cash from Financing Activities climbed as much as 7447.06% in 2025 and fell as far as 18190.91% in 2025.
- Year by year, Cash from Financing Activities stood at -$400000.0 in 2022, then plunged by 325.0% to -$1.7 million in 2023, then soared by 147.06% to $800000.0 in 2024, then soared by 37.5% to $1.1 million in 2025, then slumped by 2763.64% to -$29.3 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$29.3 million in Q2 2026, -$1.6 million in Q1 2026, and $1.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Varex Imaging | 450.24 Mn | 375.84 Mn | 72.60 Mn | -29.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -29.30 Mn |
| Apr 3, 2026 | -29.30 Mn |
| Jan 2, 2026 | -1.60 Mn |
| Jan 2, 2026 | -1.60 Mn |
| Oct 3, 2025 | 1.10 Mn |
| Oct 3, 2025 | 1.10 Mn |
| Jul 4, 2025 | -201.20 Mn |
| Jul 4, 2025 | -201.20 Mn |
| Apr 4, 2025 | -700,000.00 |
| Apr 4, 2025 | -700,000.00 |
| Jan 3, 2025 | 124.90 Mn |
| Jan 3, 2025 | 124.90 Mn |
| Sep 27, 2024 | 800,000.00 |
| Sep 27, 2024 | 800,000.00 |
| Jun 28, 2024 | -1.10 Mn |
| Jun 28, 2024 | -1.10 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Dec 29, 2023 | -1.70 Mn |
| Dec 29, 2023 | -1.70 Mn |